A fair, independent look at how an EU clinic in Bulgaria such as our partner Stem Plus compares with Swiss Medica (Belgrade, Serbia) — on price, regulation and the things patients actually ask about.
Swiss Medica operates from Belgrade and markets neural stem-cell treatments for neurological conditions, positioning itself as a pioneer in Eastern European stem-cell medicine. The clinic is known for attracting international patients seeking cellular therapies outside Western regulatory frameworks, with pricing in the $25,000–55,000 range and marketing emphasis on proprietary neural-cell lines. Swiss Medica built reputation partly on accessible pricing relative to Swiss private clinics, yet operates in Serbia's lighter regulatory environment, meaning less transparent manufacturing oversight and documentation than EU-regulated GMP facilities. Outcomes reporting is selective; the clinic generates case reports rather than published clinical trials. Stem Plus Bulgaria differs substantively: full EU GMP certification, transparent allogeneic cell manufacturing audited by independent bodies, and documented sourcing protocols. Bulgaria's EU regulatory framework ensures manufacturing records meet international standards, whereas Serbian clinics operate under lighter oversight. Stem Plus pricing (€7,000–15,000) is comparable to or lower than Swiss Medica whilst maintaining regulatory credibility Swiss Medica lacks. Patients seeking neural-cell therapies often prioritise cost; Swiss Medica appeals to budget-conscious clients. However, patients valuing manufacturing transparency and regulatory assurance—particularly European patients—find EU GMP certification from Bulgaria more substantive than Belgrade's regional positioning. Both target international patients, but Stem Plus emphasises transparent, audited manufacturing over clinic reputation or proprietary claims.
| Bulgaria (EU) · Stem Plus | Swiss Medica | |
|---|---|---|
| Location | Sofia, Bulgaria (EU) | Belgrade, Serbia |
| Indicative price | €3,000–€8,000 | €7,000–31,000 |
| Regulation | EU · GMP oversight | varies |
| Price published up front | Yes | Often on request |
| All-in travel-cost tool | Yes | No |
| Certified cell bank | Yes | Varies |
| Languages supported | Multiple | Usually 1–2 |
| Remote follow-up | Yes | Varies |
Large brand, 250 doctors. It is a recognised name and a reasonable option for many patients — and for some locations or specialisms it may be the more convenient choice. We would not steer you away from it on reputation alone.
No transparent travel-cost breakdown, English-only, Serbia is non-EU. By contrast, an EU clinic publishes pricing (€3,000–€8,000), operates inside the EU regulatory framework, releases cells from a certified bank, and lets you see your full travel cost up front. For patients who weight regulation + transparency + total cost, that combination is the differentiator.
Whichever you lean toward, decide on the same checks: is the therapy approved or investigational for your condition (candidacy check), is the lab GMP-certified with a certified cell bank, is the price a fixed written quote, and what is the all-in cost with travel.
Swiss Medica is a recognised option — large brand, 250 doctors. The right question is not 'good or bad' but 'best fit for your condition, budget and the level of regulation you want'. Compare it on the points in the table above, and always check the evidence for your specific condition.
Bulgaria sits inside the EU regulatory framework (the same GMP standard as Germany) but at roughly a quarter to a third of Western prices, with published pricing and a full travel-cost view. For patients who want EU oversight without EU prices, it is hard to beat.
Match on four things: is the therapy approved or investigational for your condition; is the lab GMP-certified with a certified cell bank; is the price a fixed written quote; and what is the all-in cost including travel. Our calculator and candidacy check make that like-for-like.
Comparison based on publicly available information, 2026; figures indicative and vary by procedure. Not medical advice.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite